The Klotho Protein Supports Redox Balance and Metabolic Functions of Cardiomyocytes During Ischemia/reperfusion Injury

Overview

Journal Cardiol J

Specialty Cardiology & Vascular Diseases

Date 2021 Dec 30

PMID 34967938

Citations 6

Authors

Agnieszka Olejnik

Marta Banaszkiewicz

Anna Krzywonos-Zawadzka

Iwona Bil-Lula

Affiliations

Soon will be listed here.

Abstract

Background: Acute heart ischemia followed by reperfusion leads to overproduction of reactive oxygen/ /nitrogen species (ROS/RNS), disrupted expression of nitric oxide synthase (NOS) and unbalanced glucose metabolism. Klotho is a membrane-bound or soluble protein that exerts protective activity in many organs. While Klotho is produced mainly in the kidneys and brain, it has been recently proven that Klotho is expressed in the cardiomyocytes as well. This study aimed to show the influence of the Klotho protein on oxidative/nitrosative stress and metabolic function of the cardiomyocytes subjected to ischemia/reperfusion (I/R) injury.

Methods: Human cardiac myocytes underwent in vitro chemical I/R (with sodium cyanide and 2-deoxyglucose), in the presence or absence of the recombinant human Klotho protein. The present study included an investigation of cell injury markers, level of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), level of oxidative/nitrosative stress and metabolic processes of the cardiomyocytes.

Results: Administration of Klotho protein resulted in mitigation of injury, decreased level of NOX2 and NOX4, reduced generation of ROS/RNS and hydrogen peroxide (H2O2), decreased expression of inducible NOS and limited production of nitrates/nitrites in cells under I/R. Glucose uptake and lactate production in the cardiomyocytes subjected to I/R were normalized after Klotho supplementation.

Conclusions: The Klotho protein participates in the regulation of redox balance and supports metabolic homeostasis of the cardiomyocytes and hence, contributes to protection against I/R injury.

Citing Articles

Involvement of ADAM17-Klotho Crosstalk in High Glucose-Induced Alterations of Podocyte Function.

Rogacka D, Rachubik P, Typiak M, Kulesza T, Audzeyenka I, Saleem M Int J Mol Sci. 2025; 26(2).

PMID: 39859443 PMC: 11765903. DOI: 10.3390/ijms26020731.

Klotho relieves HO-induced lens epithelial cell damage via suppression of NOX4.

Zhou Y, Zhao T Int Ophthalmol. 2024; 44(1):417.

PMID: 39520585 DOI: 10.1007/s10792-024-03341-0.

Cannabinoid Receptor-2 agonist AM1241 Attenuates Myocardial Ischemia-Reperfusion-Induced Oxidative Stress in Rats via Nrf2/HO-1 Pathway.

Zhang M, Tian Q, Liu J Med Princ Pract. 2024; 33(6):597-606.

PMID: 39134017 PMC: 11631038. DOI: 10.1159/000540751.

Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases.

Hang L, Zhang Y, Zhang Z, Jiang H, Xia L Cardiovasc Drugs Ther. 2024; .

PMID: 38236378 DOI: 10.1007/s10557-024-07545-5.

Klotho inhibits IGF1R/PI3K/AKT signalling pathway and protects the heart from oxidative stress during ischemia/reperfusion injury.

Olejnik A, Radajewska A, Krzywonos-Zawadzka A, Bil-Lula I Sci Rep. 2023; 13(1):20312.

PMID: 37985893 PMC: 10662387. DOI: 10.1038/s41598-023-47686-5.

References

Bil-Lula I, Lin H, Bialy D, Wawrzynska M, Diebel L, Sawicka J . Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury. J Cell Mol Med. 2016; 20(6):1086-94. PMC: 4882990. DOI: 10.1111/jcmm.12827. View

Stanley W, Hall J, Stone C, Hacker T . Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake. Am J Physiol. 1992; 262(1 Pt 2):H91-6. DOI: 10.1152/ajpheart.1992.262.1.H91. View

Olejnik A, Krzywonos-Zawadzka A, Banaszkiewicz M, Bil-Lula I . Klotho protein contributes to cardioprotection during ischaemia/reperfusion injury. J Cell Mol Med. 2020; 24(11):6448-6458. PMC: 7294144. DOI: 10.1111/jcmm.15293. View

Zhang Y, Liu G, Gao X . Attenuation of protects cardiomyocytes against hypoxic stress through maintenance of glycolysis. Biosci Rep. 2017; 37(6). PMC: 5672082. DOI: 10.1042/BSR20170925. View

Hu M, Shi M, Gillings N, Flores B, Takahashi M, Kuro-O M . Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int. 2017; 91(5):1104-1114. PMC: 5592833. DOI: 10.1016/j.kint.2016.10.034. View

Krzywonos-Zawadzka A, Franczak A, Sawicki G, Bil-Lula I . Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury. Cardiol Res Pract. 2020; 2020:1561478. PMC: 7166281. DOI: 10.1155/2020/1561478. View

Liu Y, Zhang Q . Periodontitis aggravated pancreatic β-cell dysfunction in diabetic mice through interleukin-12 regulation on Klotho. J Diabetes Investig. 2016; 7(3):303-11. PMC: 4847883. DOI: 10.1111/jdi.12410. View

Yang K, Nie L, Huang Y, Zhang J, Xiao T, Guan X . Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein. Toxicol Lett. 2012; 215(2):77-83. DOI: 10.1016/j.toxlet.2012.10.004. View

Kalyanaraman B, Darley-Usmar V, Davies K, Dennery P, Forman H, Grisham M . Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med. 2011; 52(1):1-6. PMC: 3911769. DOI: 10.1016/j.freeradbiomed.2011.09.030. View

10.

Krzywonos-Zawadzka A, Franczak A, Olejnik A, Radomski M, Gilmer J, Sawicki G . Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury. J Cell Mol Med. 2019; 23(4):2836-2848. PMC: 6433672. DOI: 10.1111/jcmm.14191. View

11.

Yang K, Wang C, Nie L, Zhao X, Gu J, Guan X . Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy. J Am Soc Nephrol. 2015; 26(10):2434-46. PMC: 4587686. DOI: 10.1681/ASN.2014060543. View

12.

Qian Y, Guo X, Che L, Guan X, Wu B, Lu R . Klotho Reduces Necroptosis by Targeting Oxidative Stress Involved in Renal Ischemic-Reperfusion Injury. Cell Physiol Biochem. 2018; 45(6):2268-2282. DOI: 10.1159/000488172. View

13.

Mitobe M, Yoshida T, Sugiura H, Shirota S, Tsuchiya K, Nihei H . Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol. 2005; 101(2):e67-74. DOI: 10.1159/000086500. View

14.

Sugiura H, Yoshida T, Tsuchiya K, Mitobe M, Nishimura S, Shirota S . Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant. 2005; 20(12):2636-45. DOI: 10.1093/ndt/gfi165. View

15.

Corsetti G, Pasini E, Scarabelli T, Romano C, Agrawal P, Chen-Scarabelli C . Decreased expression of Klotho in cardiac atria biopsy samples from patients at higher risk of atherosclerotic cardiovascular disease. J Geriatr Cardiol. 2016; 13(8):701-711. PMC: 5067432. DOI: 10.11909/j.issn.1671-5411.2016.08.009. View

16.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

17.

Kuroda J, Ago T, Matsushima S, Zhai P, Schneider M, Sadoshima J . NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A. 2010; 107(35):15565-70. PMC: 2932625. DOI: 10.1073/pnas.1002178107. View

18.

Heusch P, Aker S, Boengler K, Deindl E, van de Sand A, Klein K . Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation. Am J Physiol Heart Circ Physiol. 2010; 299(2):H446-53. DOI: 10.1152/ajpheart.01034.2009. View

19.

Kim J, Hwang K, Park K, Kong I, Cha S . Biological Role of Anti-aging Protein Klotho. J Lifestyle Med. 2015; 5(1):1-6. PMC: 4608225. DOI: 10.15280/jlm.2015.5.1.1. View

20.

Yamamoto M, Clark J, Pastor J, Gurnani P, Nandi A, Kurosu H . Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem. 2005; 280(45):38029-34. PMC: 2515369. DOI: 10.1074/jbc.M509039200. View